• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏性肺炎的诊断与治疗:德国呼吸学会和德国变态反应与临床免疫学会S2k指南

Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology.

作者信息

Koschel D, Behr J, Berger M, Bonella F, Hamer O, Joest Marcus, Jonigk Danny, Kreuter Michael, Leuschner Gabriela, Nowak Dennis, Raulf Monika, Rehbock Beate, Schreiber Jens, Sitter Helmut, Theegarten Dirk, Costabel Ulrich

机构信息

Department of Pneumology, Lungenzentrum Coswig, Coswig, Germany.

Division of Pneumology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

出版信息

Respiration. 2025;104(7):485-528. doi: 10.1159/000543675. Epub 2025 Jan 27.

DOI:10.1159/000543675
PMID:
39870058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12215178/
Abstract

German recommendations for the diagnosis of hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, were last published in 2007. The current S2k Guideline for the Diagnosis and Treatment of Hypersensitivity Pneumonitis replaces these diagnostic recommendations. They were supplemented by the aspect of chronic, and in particular of the chronic fibrotic phenotype of HP, and also, as the first HP guideline, include treatment recommendations. Based on current scientific evidence and on expert opinion, 12 consensus recommendations were developed. They include important statements summarizing the diagnostic process, the treatment indication and therapeutic strategies for patients with HP. Particular emphasis was placed on the different clinical courses (acute and chronic) and their characteristics (inflammatory and/or fibrotic pattern), which present differential diagnostic challenges and ultimately result in different treatment approaches. In addition to general information (diagnosis, classification, clinical disease course, epidemiology, pathogenesis, risk factors, prognosis, and special aspects associated with occupational disease), the guideline will present the various clinical disease entities of HP, some in detail, others in tabular form. A major focus is on the various diagnostic steps and the different treatment approaches. The background information serves to provide a deeper understanding and inform the implementation of the recommendations. In particular, other current international guidelines for the diagnosis of HP as well as German guidelines for the diagnosis of interstitial lung diseases (ILDs) (Leitlinien zur Diagnostik interstitieller Lungenerkrankungen) in general and for the pharmacotherapy of fibrotic ILDs were integrated and considered in this guideline.

摘要

德国关于过敏性肺炎(HP)诊断的建议,也称为外源性过敏性肺泡炎,上次发布于2007年。当前的S2k过敏性肺炎诊断和治疗指南取代了这些诊断建议。这些建议补充了慢性方面,特别是HP慢性纤维化表型的内容,并且作为首个HP指南,还纳入了治疗建议。基于当前的科学证据和专家意见,制定了12条共识建议。它们包括总结HP患者诊断过程、治疗指征和治疗策略的重要声明。特别强调了不同的临床病程(急性和慢性)及其特征(炎症和/或纤维化模式),这些带来了鉴别诊断挑战并最终导致不同的治疗方法。除了一般信息(诊断、分类、临床病程、流行病学、发病机制、危险因素、预后以及与职业病相关的特殊方面)外,该指南还将介绍HP的各种临床疾病实体,一些详细介绍,另一些以表格形式呈现。主要重点是各种诊断步骤和不同的治疗方法。背景信息有助于提供更深入的理解并为建议的实施提供信息。特别是,本指南整合并考虑了其他当前国际HP诊断指南以及德国间质性肺疾病(ILDs)诊断指南(间质性肺疾病诊断指南)以及纤维化ILDs药物治疗指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a97a56736423/res-2025-0104-0007-543675_F12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/3b440c8065e8/res-2025-0104-0007-543675_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/ba0d9f277d26/res-2025-0104-0007-543675_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/6c8818044dfa/res-2025-0104-0007-543675_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/f8d8b5eb6468/res-2025-0104-0007-543675_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/9db80d4cf3a9/res-2025-0104-0007-543675_F05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/b4f857360e0e/res-2025-0104-0007-543675_F06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/2ff01b207339/res-2025-0104-0007-543675_F07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a84af5c88de5/res-2025-0104-0007-543675_F08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/8ab99b1906df/res-2025-0104-0007-543675_F09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a26f2c53b3b5/res-2025-0104-0007-543675_F10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a7f3a1a18d8d/res-2025-0104-0007-543675_F11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a97a56736423/res-2025-0104-0007-543675_F12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/3b440c8065e8/res-2025-0104-0007-543675_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/ba0d9f277d26/res-2025-0104-0007-543675_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/6c8818044dfa/res-2025-0104-0007-543675_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/f8d8b5eb6468/res-2025-0104-0007-543675_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/9db80d4cf3a9/res-2025-0104-0007-543675_F05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/b4f857360e0e/res-2025-0104-0007-543675_F06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/2ff01b207339/res-2025-0104-0007-543675_F07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a84af5c88de5/res-2025-0104-0007-543675_F08.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/8ab99b1906df/res-2025-0104-0007-543675_F09.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a26f2c53b3b5/res-2025-0104-0007-543675_F10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a7f3a1a18d8d/res-2025-0104-0007-543675_F11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a18/12215178/a97a56736423/res-2025-0104-0007-543675_F12.jpg

相似文献

1
Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology.过敏性肺炎的诊断与治疗:德国呼吸学会和德国变态反应与临床免疫学会S2k指南
Respiration. 2025;104(7):485-528. doi: 10.1159/000543675. Epub 2025 Jan 27.
2
[Diagnosis and Treatment of Hypersensitivity Pneumonitis - S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology].[过敏性肺炎的诊断与治疗——德国呼吸学会和德国变态反应与临床免疫学会S2k指南]
Pneumologie. 2024 Dec;78(12):963-1002. doi: 10.1055/a-2369-8458. Epub 2024 Sep 3.
3
Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.临床指南和支付方政策对慢性下腰痛融合治疗的影响。
Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S144-63. doi: 10.1097/BRS.0b013e31822ef5b4.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Importance of early detection and treatment of occupational hypersensitivity pneumonitis.职业性过敏性肺炎早期检测与治疗的重要性。
J Occup Health. 2025 Jan 7;67(1). doi: 10.1093/joccuh/uiaf026.
6
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.卫生技术评估中决策分析模型良好实践指南综述。
Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360.
7
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
[S2e guidelines on the treatment of polymyalgia rheumatica: update 2024 : Evidence-based guidelines of the German Society for Rheumatology and Clinical Immunology (DGRh), the Austrian Society for Rheumatology and Rehabilitation (ÖGR) and the Swiss Society for Rheumatology (SGR) and the participating medical scientific specialist societies and other organizations].[风湿性多肌痛治疗的S2e指南:2024年更新:德国风湿病与临床免疫学协会(DGRh)、奥地利风湿病与康复协会(ÖGR)、瑞士风湿病协会(SGR)以及参与的医学科学专业协会和其他组织的循证指南]
Z Rheumatol. 2025 Jun 25. doi: 10.1007/s00393-025-01667-3.
10
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.

本文引用的文献

1
Use of the FFP2 mask as an effective therapeutic measure in a case of hypersensitivity pneumonitis.在一例过敏性肺炎病例中使用FFP2口罩作为一种有效的治疗措施。
Open Respir Arch. 2023 Oct 19;5(4):100280. doi: 10.1016/j.opresp.2023.100280. eCollection 2023 Oct-Dec.
2
Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.纤维化性过敏性肺炎和特发性肺纤维化患者的急性加重和进展性肺纤维化的拟议标准。
Respiration. 2023;102(9):803-812. doi: 10.1159/000533312. Epub 2023 Aug 24.
3
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
非特发性肺纤维化间质性肺疾病中的端粒长度与免疫抑制。
Eur Respir J. 2023 Nov 29;62(5). doi: 10.1183/13993003.00441-2023. Print 2023 Nov.
4
Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.特发性肺纤维化和纤维化性过敏性肺炎临床实践指南中放射学模式的整合与应用
Chest. 2023 Dec;164(6):1466-1475. doi: 10.1016/j.chest.2023.07.068. Epub 2023 Aug 2.
5
Expiratory CT scan: When to do it and how to interpret it.呼气期CT扫描:何时进行及如何解读
Radiologia (Engl Ed). 2023 Jul-Aug;65(4):352-361. doi: 10.1016/j.rxeng.2023.01.008. Epub 2023 Jul 12.
6
Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes.过敏性肺炎的临床特征:非纤维化和纤维化亚型。
Chin Med J (Engl). 2023 Dec 5;136(23):2839-2846. doi: 10.1097/CM9.0000000000002613.
7
Hypersensitivity pneumonitis due to metal working fluids: Detection of specific IgG antibodies to microbial antigens.金属加工液致过敏性肺炎:微生物抗原特异性 IgG 抗体的检测。
Respir Physiol Neurobiol. 2023 Sep;315:104107. doi: 10.1016/j.resp.2023.104107. Epub 2023 Jul 13.
8
Utility of budgerigar/pigeon/parrot-specific IgG antibody with ImmunoCAP® in bird-related hypersensitivity pneumonitis caused by other bird species and duvet.其他鸟类和羽绒引起的与鸟类相关的过敏性肺炎中,利用 ImmunoCAP® 检测虎皮鹦鹉/鸽子/鹦鹉特异性 IgG 抗体的效用。
Respir Investig. 2023 Jul;61(4):520-526. doi: 10.1016/j.resinv.2023.05.001. Epub 2023 Jun 7.
9
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.吡非尼酮治疗纤维化型过敏性肺炎:一项疗效和安全性的双盲、随机临床试验。
Thorax. 2023 Nov;78(11):1097-1104. doi: 10.1136/thorax-2022-219795. Epub 2023 Apr 7.
10
Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis.纤维化评分可预测纤维化性过敏性肺炎患者的死亡率。
Front Med (Lausanne). 2023 Mar 21;10:1131070. doi: 10.3389/fmed.2023.1131070. eCollection 2023.